Knowles, James External Entity

Publications

Sort by

Selected publications

  • A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors.  Breast cancer research : BCR2013 Academic Article GET IT
    Times cited: 32

Other